NANCY BRADDOCK: Open Payments
NPI 1437275252 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 32 payments from 9 companies in 2025. Trend: 2023 $113 · 2024 $620 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $493 |
| Phathom Pharmaceuticals, Inc. | 3 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $97 |
| ABBVIE INC. | 3 | $70 |
| Celltrion USA Inc. | 3 | $68 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
| Ardelyx, Inc. | 2 | $43 |
| GENZYME CORPORATION | 1 | $27 |
| Exact Sciences Corporation | 1 | $18 |
Products named: TREMFYA, VOQUEZNA, RINVOQ, VEGZELMA, IQIRVO, ENTYVIO, IBSRELA, EOHILIA.
Industry payments across IL — which companies pay providers there.
